Schedule 13G ownership disclosure
ASLAN PHARMACEUTICALS LTD
Security class unavailable · CUSIP: 04522R200
Event date: 2024-03-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 25,000,000
- Percent of class
- 4.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-024796
- Form type
- SC 13G
- Filer
- ASLAN Pharmaceuticals Ltd
- CIK
- CIK 1722926
- Filed
- Mar 21, 2024
- Reporting period
- Mar 12, 2024
- Description
- Schedule 13G beneficial ownership